Correlation Between RAPT Therapeutics and Mineralys Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RAPT Therapeutics and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RAPT Therapeutics and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RAPT Therapeutics and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on RAPT Therapeutics and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RAPT Therapeutics with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of RAPT Therapeutics and Mineralys Therapeutics,.

Diversification Opportunities for RAPT Therapeutics and Mineralys Therapeutics,

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between RAPT and Mineralys is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding RAPT Therapeutics and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and RAPT Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RAPT Therapeutics are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of RAPT Therapeutics i.e., RAPT Therapeutics and Mineralys Therapeutics, go up and down completely randomly.

Pair Corralation between RAPT Therapeutics and Mineralys Therapeutics,

Given the investment horizon of 90 days RAPT Therapeutics is expected to under-perform the Mineralys Therapeutics,. In addition to that, RAPT Therapeutics is 1.67 times more volatile than Mineralys Therapeutics, Common. It trades about -0.04 of its total potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about 0.01 per unit of volatility. If you would invest  1,600  in Mineralys Therapeutics, Common on September 4, 2024 and sell it today you would lose (251.00) from holding Mineralys Therapeutics, Common or give up 15.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy92.32%
ValuesDaily Returns

RAPT Therapeutics  vs.  Mineralys Therapeutics, Common

 Performance 
       Timeline  
RAPT Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days RAPT Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Mineralys Therapeutics, 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal basic indicators, Mineralys Therapeutics, unveiled solid returns over the last few months and may actually be approaching a breakup point.

RAPT Therapeutics and Mineralys Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RAPT Therapeutics and Mineralys Therapeutics,

The main advantage of trading using opposite RAPT Therapeutics and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RAPT Therapeutics position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.
The idea behind RAPT Therapeutics and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device